VEGFA and idiopathic pulmonary fibrosis: According to a majority of studies, VEGF serum concentration increases as inflammation advances during IPF exacerbation, proving its role as a predictive disease progression biomarker that is helpful in the early identification of those patients who respond to antifibrotic therapy [82].